We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
-1.29%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$3.39B
AUM Growth
+$526M
Cap. Flow
+$586M
Cap. Flow %
17.28%
Top 10 Hldgs %
16.92%
Holding
1,543
New
205
Increased
822
Reduced
368
Closed
82
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNS icon
1251
Scotiabank
BNS
$108B
$219K 0.01%
3,783
-509
-12% -$31.7K
GPRE icon
1252
Green Plains
GPRE
$1.09B
$218K 0.01%
5,836
-825
-12% -$32.9K
SCHO icon
1253
Schwab Short-Term US Treasury ETF
SCHO
$12.9B
$218K 0.01%
+8,608
New +$218K
UNG icon
1254
United States Natural Gas Fund
UNG
$494M
$218K 0.01%
+617
New +$214K
ARUN
1255
DELISTED
ARUBA NETWORKS, INC.
ARUN
$218K 0.01%
10,125
AKAM icon
1256
Akamai
AKAM
$16.8B
$217K 0.01%
+3,622
New +$218K
ORAN
1257
DELISTED
Orange
ORAN
$217K 0.01%
+14,743
New +$224K
OILT
1258
DELISTED
OILTANKING PARTNERS L P UIT LTD PARTNERSHIP INT (DE)
OILT
$217K 0.01%
+4,368
New +$213K
VMO icon
1259
Invesco Municipal Opportunity Trust
VMO
$663M
$216K 0.01%
17,259
-8,873
-34% -$110K
GWPH
1260
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$216K 0.01%
+2,668
New +$236K
AVP
1261
DELISTED
Avon Products, Inc.
AVP
$216K 0.01%
17,125
+2,035
+13% +$27.9K
FCO
1262
DELISTED
abrdn Global Income Fund
FCO
$214K 0.01%
20,000
IFLN
1263
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$306M
$214K 0.01%
11,229
-275
-2% -$5.32K
BME icon
1264
BlackRock Health Sciences Trust
BME
$577M
$213K 0.01%
+5,545
New +$204K
EFO icon
1265
ProShares Ultra MSCI EAFE
EFO
$29.4M
$213K 0.01%
6,105
GEO icon
1266
The GEO Group
GEO
$4.18B
$213K 0.01%
+8,348
New +$203K
NWBI icon
1267
Northwest Bancshares
NWBI
$2.29B
$211K 0.01%
17,472
+178
+1% +$2.25K
SPEU icon
1268
State Street SPDR Portfolio Europe ETF
SPEU
$742M
$211K 0.01%
+5,748
New +$220K
TT icon
1269
Trane Technologies
TT
$106B
$211K 0.01%
3,737
-161
-4% -$9.76K
PUW
1270
DELISTED
Invesco WilderHill Progressive Energy ETF
PUW
$211K 0.01%
7,063
+843
+14% +$27.6K
LGF
1271
DELISTED
Lions Gate Entertainment
LGF
$211K 0.01%
+6,395
New +$203K
IVOG icon
1272
Vanguard S&P Mid-Cap 400 Growth ETF
IVOG
$1.71B
$210K 0.01%
4,494
-106
-2% -$5.06K
SCHP icon
1273
Schwab US TIPS ETF
SCHP
$16.2B
$210K 0.01%
+7,764
New +$215K
DCT
1274
DELISTED
DCT Industrial Trust Inc.
DCT
$210K 0.01%
6,999
+182
+3% +$5.75K
NOK icon
1275
Nokia
NOK
$52.7B
$209K 0.01%
24,665
+436
+2% +$3.51K

Similar funds

Cambridge Investment Research Advisors's Q3 2014 Portfolio in Review

As of Q3 2014, Cambridge Investment Research Advisors held 1,543 positions worth $3.39B, up 18% from $2.87B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Cambridge Investment Research Advisors deployed $586M of net new capital in Q3 2014, opening 205 new positions and adding to 822 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 556,997 shares worth $101M.

By sector, the portfolio is most concentrated in Energy at 5.4% of assets, down from 6.5% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was iShares Russell 3000 ETF, an estimated $20M trimmed.

  • Cambridge Investment Research Advisors's largest Q3 2014 buy was Vanguard S&P 500 ETF: 556,997 shares worth $101M.
  • Cambridge Investment Research Advisors added most to Barclays Bank Plc in Q3 2014, an estimated $45.8M increase.
  • Cambridge Investment Research Advisors's biggest Q3 2014 reduction was iShares Russell 3000 ETF, cutting an estimated $20M.
  • Cambridge Investment Research Advisors fully exited iShares MSCI Taiwan ETF in Q3 2014, selling an estimated $1.83M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 17% of its $3.39B portfolio in Q3 2014.
  • Cambridge Investment Research Advisors opened 205 new positions and closed 82 in Q3 2014.
  • Cambridge Investment Research Advisors's portfolio value rose 18% quarter-over-quarter to $3.39B.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2014, filed 5 Nov 2014.